Form 4 for JNJ Johnson & Johnson
Accepted 2022-02-15 20:02:45 ET · period of report 2022-02-14 · accession 0001225208-22-002211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +3,297 | 118.4K | +3% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $168.85 | -1,190 | 117.2K | -1% | -$200.9K |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | -3,297 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 3,297 | $0.00 | 118,423.00 | D | — | — | (F1) Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. |
| 2 | Common | Common Stock | 2022-02-14 | F | D | 1,190 | $168.85 | 117,233.00 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of Restricted Share Units. |
| 3 | Derivative | Restricted Share Units | 2022-02-14 | M | D | 3,297 | $0.00 | 0 | D | — · 2022-02-11 to — | 3,297 Common Stock | (F1) Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. (F1) Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. |